A novel in vitro model of tumor angiogenesis [1]

In Vitro Cellular and Developmental Biology - Animal

Volumn 36, Issue 9, 2000, Pages 555-558

  Kozien, D ^a   Gerol, M ^a   Hendey, B ^a   RayChaudhury, A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN 1;

ANGIOGENESIS; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; NEOVASCULARIZATION (PATHOLOGY); PROTEIN SYNTHESIS; SOLID TUMOR; TUMOR CELL CULTURE;

ANIMALS; CATTLE; ENDOTHELIUM, VASCULAR; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PULMONARY ARTERY; THROMBOSPONDIN 1; TUMOR CELLS, CULTURED;

EID: 0034496106     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1290/1071-2690(2000)036<0555:ANIVMO>2.0.CO;2     Document Type: Letter

References (13)

1. Three dimensional endothelial-tumor epithelial cells interactions in human cervical cancer
2. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
3. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
4. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
5. Differential expression of extracellular proteins is correlated with angiogenesis in vitro
6. An in vitro three-dimensional coculture model of cerebral microvascular angiogenesis and differentiation
7. Comparison of normal and tumorigenic endothelial cells: Differences in thrombospondin production and responses to transforming growth factor-beta
8. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis
9. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
10. The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression
11. Transfection of thrombospondin-1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
12. Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors
13. Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer by fusion with immortal mammary epithelial cells